Track topics on Twitter Track topics that are important to you
Symcel partners with Karolinska Institutet to validate calScreener in clinical antimicrobial susceptibility testing. The collaboration will evaluate Symcel’s cell-based assay...Read More... The ...
Symcel – the company behind the revolutionary cell─based assay tool for real─time cell metabolism measurements, the calScreener – has announced the appointment of two new highly experienced bo...
For the evaluation of calScreener technology as an improved method to test for combinations of antibiotics in sepsis patients
Bolaget utser två nya styrelseledamöter för att stärka tillväxten på forskningsmarknaden samt expansionen mot den kliniska diagnostikmarknaden.
The Swedish project involves a partnership between Symcel and the Karolinska Institutet, in a Horizon 2020 funded project
Antibiotikan håller på att förlora sin kraft då allt fler bakterier blir resistenta. Life Science Sweden pratade med Wilhelm Paulander och Marta Veses Garcia på Symcel om hur de vill bidra.
SymCel is a privately held Swedish company, founded in 2004, engaged in development of innovative instrumentations and methods for Biological Research.SymCel is supported by STING, Stockholm Innovatio...
We have published hundreds of SymCel AB news stories on BioPortfolio along with dozens of SymCel AB Clinical Trials and PubMed Articles about SymCel AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SymCel AB Companies in our database. You can also find out about relevant SymCel AB Drugs and Medications on this site too.
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...